- Home
- AEMD vs GCTK Comparison
AEMD vs GCTK Comparison
Compare AEMD & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEMD
- GCTK
- Stock Information
- Founded
- AEMD 1984
- GCTK 2001
- Country
- AEMD United States
- GCTK United States
- Employees
- AEMD N/A
- GCTK N/A
- Industry
- AEMD Medical/Dental Instruments
- GCTK Medical/Dental Instruments
- Sector
- AEMD Health Care
- GCTK Health Care
- Exchange
- AEMD Nasdaq
- GCTK Nasdaq
- Market Cap
- AEMD 4.1M
- GCTK 4.1M
- IPO Year
- AEMD N/A
- GCTK N/A
- Fundamental
- Price
- AEMD $1.22
- GCTK $6.59
- Analyst Decision
- AEMD Strong Buy
- GCTK
- Analyst Count
- AEMD 1
- GCTK 0
- Target Price
- AEMD $56.00
- GCTK N/A
- AVG Volume (30 Days)
- AEMD 265.2K
- GCTK 1.6M
- Earning Date
- AEMD 06-26-2025
- GCTK 08-12-2025
- Dividend Yield
- AEMD N/A
- GCTK N/A
- EPS Growth
- AEMD N/A
- GCTK N/A
- EPS
- AEMD N/A
- GCTK N/A
- Revenue
- AEMD N/A
- GCTK N/A
- Revenue This Year
- AEMD N/A
- GCTK N/A
- Revenue Next Year
- AEMD N/A
- GCTK N/A
- P/E Ratio
- AEMD N/A
- GCTK N/A
- Revenue Growth
- AEMD N/A
- GCTK N/A
- 52 Week Low
- AEMD $1.20
- GCTK $5.16
- 52 Week High
- AEMD $8.44
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- AEMD 41.34
- GCTK 35.94
- Support Level
- AEMD $1.40
- GCTK $5.94
- Resistance Level
- AEMD $2.88
- GCTK $15.90
- Average True Range (ATR)
- AEMD 0.26
- GCTK 1.57
- MACD
- AEMD -0.02
- GCTK -0.01
- Stochastic Oscillator
- AEMD 36.49
- GCTK 0.56
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.